“💊 High Intensity Statins vs Smart Alternatives: A Heart-Healthy Showdown! ❤️📉”
Mar 09, 2025•2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
🔬 Study Overview: A meta-analysis comparing alternative LDL cholesterol-lowering strategies (moderate-intensity statins + ezetimibe) vs high-intensity statins in patients with ASCVD.
📊 Key Findings:
✅ No significant difference in 3-year cardiovascular events (7.5% vs 7.7%)
📉 Lower LDL cholesterol in the alternative strategy (64.8 vs 68.5 mg/dL)
🩸 Reduced risk of new-onset diabetes (10.2% vs 11.9%)
💊 Fewer therapy discontinuations due to intolerance (4.0% vs 6.7%)
⚖️ Conclusion: The alternative strategy offers comparable efficacy with better tolerability and safety, making it a viable option for patients intolerant to high-intensity statins.
For the best experience, listen in Metacast app for iOS or Android